Venetoclax plus ML385 defeats AML chemotherapy resistance
In a groundbreaking advancement for acute myeloid leukemia (AML) treatment, researchers have uncovered a promising combination therapy that holds the ...
Tag: Nrf2 pathway inhibition** **Açıklama:** 1. **AML targeted therapy:** Makalenin ana odağı AML (akut miyeloid lösemi) ve spesifik moleküler hedeflere yönelik yeni bir tedavi yakla
